Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
8 hedge funds and large institutions have $2.98M invested in Genetic Technologies Ltd. in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
38% less funds holding
Funds holding: 13 → 8 (-5)
39% less capital invested
Capital invested by funds: $4.87M → $2.98M (-$1.9M)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$398K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$87.2K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$75.4K |
| 4 |
Millennium Management
New York
|
+$59.1K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$168K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$79K |
| 4 |
Jane Street
New York
|
-$71K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $1.86M | -$168K | -2,000 | -6% |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $459K | +$75.4K | +900 | +14% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $323K | +$398K | +4,751 | +839% |
|
|
4
Millennium Management
New York
| $208K | +$59.1K | +705 | +26% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $63K | +$87.2K | +1,041 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $44K | -$111K | -1,321 | -65% |
|
7
Morgan Stanley
New York
| $16K | +$10.6K | +127 | +90% |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $8K | +$11.6K | +138 | New |
|
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$79K | -750 | Closed |
|
|
10
Jane Street
New York
| – | -$71K | -674 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$10K | -91 | Closed |
|
12
Creative Planning
Overland Park,
Kansas
| – | -$4K | -43 | Closed |
|
|
AIG
13
American International Group
New York
| – | -$1.84K | -18 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | -$2K | -18 | Closed |
|
GENE Hedge Fund Activity: Q2 2015 in Review
8 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2015, worth a combined $2.98M — down 39% from $4.87M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of GENE and 2 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $398K. The largest seller was Renaissance Technologies, cutting an estimated $168K.
- 8 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2015, down from 13 in Q1 2015.
- Funds reported $2.98M of Genetic Technologies Ltd. stock for Q2 2015, down 39% quarter-over-quarter.
- 2 funds opened new Genetic Technologies Ltd. positions in Q2 2015 and 7 closed out, a net change of -5 holders.
- The largest Genetic Technologies Ltd. buyer in Q2 2015 was Virtu KCG Holdings, an estimated $398K added.
- The largest Genetic Technologies Ltd. seller in Q2 2015 was Renaissance Technologies, an estimated $168K sold.
Based on aggregated 13F filings for Q2 2015.